<html lang="en">
<head>
<meta charset="utf-8"/>
<meta name="viewport" content="width=device-width, initial-scale=1.0"/>
<title>ODDA - Drug Safety Communications</title>
<link href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css" rel="stylesheet"/>
<style>
    * {
      margin: 0;
      padding: 0;
      box-sizing: border-box;
    }

    body {
      font-family: Arial, sans-serif;
      background-color: #f5f5f5;
      line-height: 1.6;
    }

    /* Header */
    .header {
      background: linear-gradient(135deg, #2c3e50 0%, #34495e 100%);
      color: white;
      padding: 15px 20px;
      display: flex;
      justify-content: space-between;
      align-items: center;
      box-shadow: 0 2px 10px rgba(0, 0, 0, 0.1);
    }

    .logo-section {
      display: flex;
      align-items: center;
      gap: 10px;
    }

    .logo {
      width: 40px;
      height: 40px;
      background: linear-gradient(135deg, #3498db 0%, #2980b9 100%);
      border-radius: 8px;
      display: flex;
      align-items: center;
      justify-content: center;
      font-weight: bold;
      font-size: 14px;
    }

    .brand-text {
      display: flex;
      flex-direction: column;
    }

    .brand-name {
      font-size: 18px;
      font-weight: bold;
      margin: 0;
    }

    .brand-subtitle {
      font-size: 12px;
      color: #bdc3c7;
      margin: 0;
    }

    .menu-icon {
      font-size: 24px;
      cursor: pointer;
    }

    /* Hero Section */
    .hero-section {
      background: linear-gradient(135deg, #2c3e50 0%, #34495e 50%, #3498db 100%);
      color: white;
      text-align: center;
      padding: 60px 20px;
      position: relative;
      overflow: hidden;
    }

    .hero-section::before {
      content: '';
      position: absolute;
      top: 0;
      right: 0;
      width: 100%;
      height: 100%;
      background: url('data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 1000 300"><path d="M0,160L48,149.3C96,139,192,117,288,122.7C384,128,480,160,576,165.3C672,171,768,149,864,133.3C960,117,1056,107,1152,122.7C1248,139,1344,181,1392,202.7L1440,224L1440,0L1392,0C1344,0,1248,0,1152,0C1056,0,960,0,864,0C768,0,672,0,576,0C480,0,384,0,288,0C192,0,96,0,48,0L0,0Z" fill="%23ffffff" fill-opacity="0.1"/></svg>') no-repeat;
      background-size: cover;
    }

    .hero-title {
      font-size: 2.5em;
      font-weight: bold;
      margin-bottom: 10px;
      text-shadow: 2px 2px 4px rgba(0, 0, 0, 0.3);
    }

    /* Navigation */
    .nav-breadcrumb {
      background: white;
      padding: 15px 20px;
      border-bottom: 1px solid #e9ecef;
      font-size: 14px;
    }

    .nav-breadcrumb a {
      color: #3498db;
      text-decoration: none;
      margin-right: 5px;
    }

    .nav-breadcrumb a:hover {
      text-decoration: underline;
    }

    .nav-breadcrumb span {
      color: #6c757d;
      margin: 0 5px;
    }

    /* Main Content */
    .main-container {
      max-width: 1200px;
      margin: 0 auto;
      padding: 30px 20px;
      display: grid;
      grid-template-columns: 2fr 1fr;
      gap: 30px;
    }

    /* Left Column */
    .content-section {
      background: white;
      border-radius: 10px;
      padding: 25px;
      box-shadow: 0 2px 10px rgba(0, 0, 0, 0.1);
    }

    .section-title {
      font-size: 1.5em;
      color: #2c3e50;
      margin-bottom: 20px;
      padding-bottom: 10px;
      border-bottom: 2px solid #3498db;
    }

    .intro-text {
      color: #495057;
      margin-bottom: 25px;
      line-height: 1.6;
    }

    .info-grid {
      display: grid;
      grid-template-columns: 1fr 1fr;
      gap: 20px;
      margin-bottom: 30px;
    }

    .info-item {
      padding: 15px;
      background: #f8f9fa;
      border-radius: 8px;
      border-left: 4px solid #3498db;
    }

    .info-item h4 {
      color: #2c3e50;
      margin-bottom: 8px;
      font-size: 14px;
      font-weight: 600;
    }

    .info-item p {
      color: #6c757d;
      font-size: 13px;
      line-height: 1.5;
    }

    /* Communications List */
    .communications-section {
      margin-top: 30px;
    }

    .communications-header {
      display: flex;
      justify-content: space-between;
      align-items: center;
      margin-bottom: 20px;
    }

    .communications-title {
      font-size: 1.3em;
      color: #2c3e50;
      text-transform: uppercase;
      font-weight: 600;
      margin: 0;
    }

    .refresh-button {
      background: linear-gradient(135deg, #27ae60 0%, #2ecc71 100%);
      color: white;
      border: none;
      padding: 10px 20px;
      border-radius: 25px;
      cursor: pointer;
      font-size: 14px;
      font-weight: 600;
      transition: all 0.3s ease;
      display: flex;
      align-items: center;
      gap: 8px;
    }

    .refresh-button:hover {
      background: linear-gradient(135deg, #2ecc71 0%, #27ae60 100%);
      transform: translateY(-2px);
      box-shadow: 0 4px 12px rgba(46, 204, 113, 0.3);
    }

    .refresh-button i {
      transition: transform 0.3s ease;
    }

    .refresh-button:hover i {
      transform: rotate(180deg);
    }

    .communication-item {
      background: white;
      border: 1px solid #e9ecef;
      border-radius: 8px;
      padding: 20px;
      margin-bottom: 15px;
      transition: all 0.3s ease;
      cursor: pointer;
      text-decoration: none;
      display: block;
      color: inherit;
    }

    .communication-item:hover {
      box-shadow: 0 4px 15px rgba(0, 0, 0, 0.1);
      transform: translateY(-2px);
      background-color: #f8f9fa;
    }

    .comm-date {
      color: #3498db;
      font-weight: 600;
      font-size: 14px;
      margin-bottom: 8px;
    }

    .comm-title {
      color: #3498db;
      font-size: 16px;
      font-weight: 600;
      margin-bottom: 8px;
      text-decoration: none;
      display: block;
      line-height: 1.4;
    }

    .comm-title:hover {
      color: #2980b9;
      text-decoration: underline;
    }

    .comm-description {
      color: #3498db;
      font-size: 14px;
      line-height: 1.5;
    }

    /* Hidden content for dynamic loading */
    .dynamic-content {
      display: none;
    }

    .static-content {
      display: block;
    }

    /* Archive Notice */
    .archive-notice {
      background: linear-gradient(135deg, #f39c12 0%, #e67e22 100%);
      color: white;
      padding: 15px;
      border-radius: 8px;
      margin-top: 25px;
      font-size: 14px;
    }

    .archive-notice strong {
      display: block;
      margin-bottom: 5px;
    }

    .archive-link {
      color: #fff;
      text-decoration: underline;
    }

    /* Right Sidebar */
    .sidebar {
      display: flex;
      flex-direction: column;
      gap: 20px;
    }

    .sidebar-section {
      background: white;
      border-radius: 10px;
      padding: 20px;
      box-shadow: 0 2px 10px rgba(0, 0, 0, 0.1);
    }

    .sidebar-title {
      color: #2c3e50;
      font-size: 1.1em;
      font-weight: 600;
      margin-bottom: 15px;
      padding-bottom: 8px;
      border-bottom: 2px solid #3498db;
    }

    .current-date {
      background: linear-gradient(135deg, #27ae60 0%, #2ecc71 100%);
      color: white;
      padding: 15px;
      border-radius: 8px;
      text-align: center;
      font-weight: 600;
    }

    /* Newsletter Signup */
    .newsletter-signup {
      background: linear-gradient(135deg, #8e44ad 0%, #9b59b6 100%);
      color: white;
      padding: 20px;
      border-radius: 10px;
      text-align: center;
    }

    .newsletter-title {
      font-size: 16px;
      font-weight: 600;
      margin-bottom: 15px;
    }

    .newsletter-form {
      display: flex;
      gap: 10px;
      margin-top: 15px;
    }

    .newsletter-input {
      flex: 1;
      padding: 10px;
      border: none;
      border-radius: 5px;
      font-size: 14px;
    }

    .newsletter-btn {
      background: #fff;
      color: #8e44ad;
      border: none;
      padding: 10px 15px;
      border-radius: 5px;
      font-weight: 600;
      cursor: pointer;
      transition: all 0.3s ease;
    }

    .newsletter-btn:hover {
      background: #f8f9fa;
      transform: translateY(-1px);
    }

    /* Footer */
    .footer {
      background: #2c3e50;
      color: white;
      padding: 30px 20px;
      margin-top: 50px;
    }

    .footer-content {
      max-width: 1200px;
      margin: 0 auto;
      display: grid;
      grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
      gap: 30px;
    }

    .footer-section h4 {
      margin-bottom: 15px;
      color: #3498db;
    }

    .footer-section ul {
      list-style: none;
    }

    .footer-section ul li {
      margin-bottom: 8px;
    }

    .footer-section ul li a {
      color: #bdc3c7;
      text-decoration: none;
      font-size: 14px;
    }

    .footer-section ul li a:hover {
      color: white;
    }

    .footer-bottom {
      background: #34495e;
      padding: 15px 0;
      text-align: center;
      margin-top: 20px;
    }

    .footer-bottom-content {
      max-width: 1200px;
      margin: 0 auto;
      display: flex;
      justify-content: space-between;
      align-items: center;
      flex-wrap: wrap;
      gap: 15px;
    }

    .footer-logo {
      display: flex;
      align-items: center;
      gap: 10px;
    }

    .footer-contact {
      font-size: 14px;
      color: #bdc3c7;
    }

    /* Responsive Design */
    @media (max-width: 768px) {
      .main-container {
        grid-template-columns: 1fr;
        gap: 20px;
        padding: 20px 15px;
      }

      .info-grid {
        grid-template-columns: 1fr;
      }

      .hero-title {
        font-size: 2em;
      }

      .newsletter-form {
        flex-direction: column;
      }

      .footer-bottom-content {
        flex-direction: column;
        text-align: center;
      }

      .communications-header {
        flex-direction: column;
        gap: 15px;
        align-items: flex-start;
      }
    }
  </style>
</head>
<body>
<!-- Header -->
<header class="header">
<div class="logo-section">
<div class="logo">ODDA</div>
<div class="brand-text">
<h1 class="brand-name">ODDA</h1>
<p class="brand-subtitle">Dummy It Is!</p>
</div>
</div>
<div class="menu-icon">
<i class="fas fa-bars"></i>
</div>
</header>
<!-- Hero Section -->
<section class="hero-section">
<h1 class="hero-title">Drug Safety Communications</h1>
</section>
<!-- Navigation Breadcrumb -->
<nav class="nav-breadcrumb">
<a href="#"><i class="fas fa-home"></i> Home</a>
<span>&gt;</span>
<a href="#">Drugs</a>
<span>&gt;</span>
<a href="#">Drug Safety &amp; Availability</a>
<span>&gt;</span>
<span>Drug Safety Communications</span>
</nav>
<!-- Main Content -->
<main class="main-container">
<!-- Left Column -->
<div class="content-section">
<h2 class="section-title">Drug Safety &amp; Availability</h2>
<div class="intro-text">
        The ODDA Drug Safety Communications posted on this web page are intended to provide important information to patients and health care professionals about medicines. ODDA uses this tool to update our partners and manufacturers so they can make more informed decisions about treatment.
      </div>
<div class="info-grid">
<div class="info-item">
<h4><i class="fas fa-exclamation-triangle"></i> Drug Alerts &amp; Statement</h4>
<p>Understand potential negative effects for noncommercial drugs during the clinical trials a drug company and Smart FDA approval of the FDA and pharmaceuticals approved.</p>
</div>
<div class="info-item">
<h4><i class="fas fa-comments"></i> Drug Safety Communications</h4>
<p>When we learn information about a potential new safety issue, as we review, the data from clinical clinical trials or test some of clinical FDA that we review, we may require changes.</p>
</div>
<div class="info-item">
<h4><i class="fas fa-shield-alt"></i> Drug Shortage Information</h4>
<p>Information by Drug Other that can safety information on medications by the U.S. FDA and communication on types of a medical specialist of your specific interest to you.</p>
</div>
</div>
<div class="communications-section">
<div class="communications-header">
<h3 class="communications-title">Current Drug Safety Communications</h3>
<button class="refresh-button" id="refreshBtn">
<i class="fas fa-sync-alt"></i>
Refresh Data
</button>
</div>

<div id="communicationsList">
<!-- Static FDA Links (shown initially) -->
<div class="static-content">
<a class="communication-item" href="https://www.fda.gov/safety/medical-product-safety-information/fda-adds-warning-about-rare-occurrence-serious-liver-injury-use-veozah-fezolinetant-hot-flashes-due" target="_blank">
<div class="comm-date">12/17/2024</div>
<div class="comm-title">ODDA Adds Warning About Rare Occurrence of Serious Liver Injury with Use of Veozah (fezolinetant) for Hot Flashes Due to Menopause</div>
<div class="comm-description">
    ODDA adds Boxed Warning to highlight rare but serious liver injury risk with Veozah (fezolinetant) for menopause hot flashes. Patients experiencing liver injury symptoms should stop medicine immediately and contact healthcare provider.
  </div>
</a>

<a class="communication-item" href="https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/buy-herbalcom-issues-voluntary-nationwide-recall-nhan-sam-tuyet-lien-truy-phong-hoan-capsules-due" target="_blank">
<div class="comm-date">12/13/2024</div>
<div class="comm-title">Buy-herbal.com Issues Voluntary Nationwide Recall of Nhan Sam Tuyet Lien Truy Phong Hoan Capsules Due to Undeclared Drugs</div>
<div class="comm-description">
    ODDA analysis found undeclared prescription drugs in herbal capsules marketed for gout and arthritis. Products contain furosemide, dexamethasone, and chlorpheniramine per capsule, posing serious health risks.
  </div>
</a>

<a class="communication-item" href="https://www.fda.gov/safety/medical-product-safety-information/ocaliva-obeticholic-acid-intercept-pharmaceuticals-drug-safety-communication-serious-liver-injury" target="_blank">
<div class="comm-date">12/12/2024</div>
<div class="comm-title">Ocaliva (obeticholic acid): Drug Safety Communication - Serious Liver Injury Being Observed in Patients without Cirrhosis</div>
<div class="comm-description">
    ODDA reports serious liver injury in primary biliary cholangitis patients without cirrhosis taking Ocaliva. Some cases resulted in liver transplant. Frequent liver monitoring required.
  </div>
</a>
</div>

<!-- Dynamic ODDA Links (hidden initially, shown after refresh) -->
<div class="dynamic-content" id="dynamicContent">
<a class="communication-item" href="opioid_prescribing_info.html">
<div class="comm-date">09-10-2025</div>
<div class="comm-title">ODDA Requires Opioid Pain Medicine Manufacturers to Update Prescribing Information (Long-Term Use)</div>
<div class="comm-description">
    ODDA reviewed new PMR studies and requires labeling updates for long-term opioid therapy including clearer risk language, naloxone guidance, tapering recommendations, and monitoring for misuse and overdose.
  </div>
</a>
<a class="communication-item" href="xaonlora_rems_elimination.html">
<div class="comm-date">09-10-2025</div>
<div class="comm-title">ODDA Eliminates REMS for Xaonlora</div>
<div class="comm-description">
    ODDA has removed the REMS requirement for Xaonlora; certification and immediate on-site tocilizumab requirements are lifted. Updated labeling and monitoring guidance remain in effect.
  </div>
</a>
<a class="communication-item" href="cetirizine_warning.html">
<div class="comm-date">09-10-2025</div>
<div class="comm-title">ODDA Requires Warning for Severe Itching After Stopping Cetirizine/Levocetirizine</div>
<div class="comm-description">
    ODDA requires a new warning about rare but severe pruritus after stopping long-term use of cetirizine or levocetirizine; manufacturers requested to update prescribing information and OTC labeling.
  </div>
</a>
</div>
</div>

</div>
<div class="archive-notice">
<strong>Some Drug Safety Communications (DSCs) posted from 2019 to 2015 have been archived.</strong>
        Because FDA issued newer DSCs with updated information about the medicine, to access these archived DSCs, visit the <a class="archive-link" href="#">Way Back Archive</a>.
      </div>
</div>
<!-- Right Sidebar -->
<aside class="sidebar">
<div class="sidebar-section">
<h3 class="sidebar-title">Recent ODDA Notices</h3>
<ul style="list-style:none; padding:0; margin:0;" id="sidebarNotices">
<li style="margin-bottom:10px;"><strong>Veozah Liver Warning Added</strong><br/><small>12-17-2024</small></li>
<li style="margin-bottom:10px;"><strong>Herbal Capsules Recalled</strong><br/><small>12-13-2024</small></li>
<li style="margin-bottom:10px;"><strong>Ocaliva Liver Injury Alert</strong><br/><small>12-12-2024</small></li>
</ul>
</div>
</aside>
</main>
<!-- Newsletter Signup -->
<section class="newsletter-signup">
<h3 class="newsletter-title">Subscribe to Drug Safety Communication</h3>
<p>Stay updated with the latest drug safety information and communications.</p>
<div class="newsletter-form">
<input class="newsletter-input" placeholder="Enter Your Email" type="email"/>
<button class="newsletter-btn">SUBSCRIBE</button>
</div>
</section>
<!-- Footer -->
<footer class="footer">
<div class="footer-content">
<div class="footer-section">
<h4>ODDA Archive</h4>
<ul>
<li><a href="#">Drug Safety Archives</a></li>
<li><a href="#">Historical Communications</a></li>
<li><a href="#">Archived Alerts</a></li>
</ul>
</div>
<div class="footer-section">
<h4>About ODDA</h4>
<ul>
<li><a href="#">Mission &amp; Vision</a></li>
<li><a href="#">Leadership Team</a></li>
<li><a href="#">Contact Us</a></li>
</ul>
</div>
<div class="footer-section">
<h4>Resources</h4>
<ul>
<li><a href="#">Safety Guidelines</a></li>
<li><a href="#">Research Papers</a></li>
<li><a href="#">Industry Updates</a></li>
</ul>
</div>
<div class="footer-section">
<h4>Legal</h4>
<ul>
<li><a href="#">Privacy Policy</a></li>
<li><a href="#">Terms of Service</a></li>
<li><a href="#">Disclaimer</a></li>
</ul>
</div>
</div>
<div class="footer-bottom">
<div class="footer-bottom-content">
<div class="footer-logo">
<div class="logo">ODDA</div>
<span>Contact Number: 1-888-INFO-ODDA (1-XXX-XXX-6332)</span>
</div>
<div class="footer-contact">
<p>Â© 2025 ODDA. All rights reserved.</p>
</div>
</div>
</div>
</footer>
<script>
    // JavaScript for refresh functionality
    document.addEventListener('DOMContentLoaded', function() {
      const refreshBtn = document.getElementById('refreshBtn');
      const staticContent = document.querySelector('.static-content');
      const dynamicContent = document.getElementById('dynamicContent');
      const sidebarNotices = document.getElementById('sidebarNotices');
      
      let isRefreshed = false;

      refreshBtn.addEventListener('click', function() {
        if (!isRefreshed) {
          // Hide static content and show dynamic content
          staticContent.style.display = 'none';
          dynamicContent.style.display = 'block';
          
          // Update sidebar with all notices
          sidebarNotices.innerHTML = `
            <li style="margin-bottom:10px;"><strong>Opioid Prescribing Info Updated</strong><br/><small>09-10-2025</small></li>
            <li style="margin-bottom:10px;"><strong>Xaonlora REMS Eliminated</strong><br/><small>09-10-2025</small></li>
            <li style="margin-bottom:10px;"><strong>Cetirizine Pruritus Warning</strong><br/><small>09-10-2025</small></li>
            <li style="margin-bottom:10px;"><strong>Veozah Liver Warning Added</strong><br/><small>12-17-2024</small></li>
            <li style="margin-bottom:10px;"><strong>Herbal Capsules Recalled</strong><br/><small>12-13-2024</small></li>
            <li style="margin-bottom:10px;"><strong>Ocaliva Liver Injury Alert</strong><br/><small>12-12-2024</small></li>
          `;
          
          // Update button text
          refreshBtn.innerHTML = '<i class="fas fa-sync-alt"></i> Data Refreshed';
          refreshBtn.style.background = 'linear-gradient(135deg, #3498db 0%, #2980b9 100%)';
          
          isRefreshed = true;
          
          // Show notification
          showNotification('ODDA data successfully loaded!');
        } else {
          // Reset to original state
          staticContent.style.display = 'block';
          dynamicContent.style.display = 'none';
          
          // Reset sidebar
          sidebarNotices.innerHTML = `
            <li style="margin-bottom:10px;"><strong>Veozah Liver Warning Added</strong><br/><small>12-17-2024</small></li>
            <li style="margin-bottom:10px;"><strong>Herbal Capsules Recalled</strong><br/><small>12-13-2024</small></li>
            <li style="margin-bottom:10px;"><strong>Ocaliva Liver Injury Alert</strong><br/><small>12-12-2024</small></li>
          `;
          
          // Reset button
          refreshBtn.innerHTML = '<i class="fas fa-sync-alt"></i> Refresh Data';
          refreshBtn.style.background = 'linear-gradient(135deg, #27ae60 0%, #2ecc71 100%)';
          
          isRefreshed = false;
          
          showNotification('Showing FDA communications');
        }
      });

      // Add click events to communication items
      const commItems = document.querySelectorAll('.communication-item');
      commItems.forEach(item => {
        item.addEventListener('click', function() {
          this.style.backgroundColor = '#f8f9fa';
          setTimeout(() => {
            this.style.backgroundColor = 'white';
          }, 200);
        });
      });

      // Newsletter form submission
      const newsletterBtn = document.querySelector('.newsletter-btn');
      
      newsletterBtn.addEventListener('click', function() {
        const email = document.querySelector('.newsletter-input').value;
        if (email) {
          showNotification('Thank you for subscribing to Drug Safety Communications!');
          document.querySelector('.newsletter-input').value = '';
        } else {
          showNotification('Please enter a valid email address.');
        }
      });

      // Notification function
      function showNotification(message) {
        // Create notification element
        const notification = document.createElement('div');
        notification.style.cssText = `
          position: fixed;
          top: 20px;
          right: 20px;
          background: linear-gradient(135deg, #27ae60 0%, #2ecc71 100%);
          color: white;
          padding: 15px 25px;
          border-radius: 8px;
          box-shadow: 0 4px 12px rgba(0,0,0,0.15);
          z-index: 1000;
          font-weight: 600;
          animation: slideIn 0.3s ease-out;
        `;
        notification.textContent = message;
        
        // Add animation styles
        const style = document.createElement('style');
        style.textContent = `
          @keyframes slideIn {
            from { transform: translateX(100%); opacity: 0; }
            to { transform: translateX(0); opacity: 1; }
          }
        `;
        document.head.appendChild(style);
        
        document.body.appendChild(notification);
        
        // Remove notification after 3 seconds
        setTimeout(() => {
          notification.remove();
          style.remove();
        }, 3000);
      }
    });
  </script>
</body>
</html>
